Top Biotech companies by Cash on Hand
Browse the Biotech companies with the most cash on hand. Based on the financial data of 9 Biotech companies on average had 6102974391.660692 cash on hand in 2024.
20 Jun 2024, 16:40 UTCCompanies: 9
Sort by:
Sort by:
🇨🇭1 |  | $105.85 | 0.65% | 13.96B | 9.70% | Underperform S&P500 YTD Benchamark | 💊 Pharma | 3.33% |
🇨🇭2 |  | $33.46 | -0.27% | 11.72B | -7.26% | Underperform S&P500 YTD Benchamark | 💊 Pharma | 3.96% |
🇺🇸3 |  | $1,002.95 | 0.00% | 10.84B | 14.77% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵4 |  | $36.86 | -0.70% | 7.65B | 46.83% | Outperform S&P500 YTD Benchamark | 💊 Pharma | 0.61% |
🇩🇰5 |  | $143.63 | 0.52% | 4.36B | 41.22% | Outperform S&P500 YTD Benchamark | ⚕️ Healthcare | 0.72% |
🇯🇵6 |  | $27.04 | 0.21% | 2.02B | 3.09% | Underperform S&P500 YTD Benchamark | 💊 Pharma | 4.34% |
🇺🇸7 |  | $73.97 | -0.72% | 1.93B | 4.12% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇯🇵8 |  | $10.07 | 0.35% | 1.82B | -7.84% | Underperform S&P500 YTD Benchamark | 💊 Pharma | 4.10% |
🇺🇸9 |  | $113.68 | -0.71% | 618.19M | -10.49% | Underperform S&P500 YTD Benchamark | 🏠 Real estate | 1.09% |
